Article

1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF @@113110@@
Service d'aide à la décision clinique
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Annales de Dermatologie et de Vénéréologie
Vol 133, N° 5-C1  - mai 2006
pp. 473-474
Doi : AD-05-2006-133-5-C1-0151-9638-101019-200518573
Carcinome épidermoïde mortel sur hidradénite suppurée après traitement par Infliximab
Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab
 

E. MAALOUF [1], O. FAYE [1], F. POLI [1], A. COSNES [1], J. REVUZ [1]
[1] Service de Dermatologie, Hôpital Henri Mondor, Créteil.

Tirés à part : J. REVUZ [1]

[1] Service de Dermatologie, Hôpital Henri Mondor, 51, avenue du Maréchal de Lattre-de-Tassigny, 94010 Créteil Cedex.

jean.revuz@hmn.ap-hop-paris.fr





© 2006 Elsevier Masson SAS. Tous droits réservés.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline